000			03484nam a22004095i 4500
999			_c86701 _d86701 _x1
001			86701
003			ES-MaUEC
005			20230207040611.0
007			cr nn 008mamaa
008			160901s2016 ne | s |||| 0|eng d
020			_a9789400776784
040			_aES-MaUEC
050		4	_aRC669.9 _b.B56 2016 EB
082	0	4	_a614.5999
245	0	0	_aBiomarkers in cardiovascular disease _cedited by Vinood B Patel, Victor R Preedy
260			_aDordrecht _bSpringer _c2016
300			_a1 recurso en línea (213 ilustraciones, 138 ilustraciones en color)
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	1		_aBiomarkers in Disease: Methods, Discoveries and Applications
505	0		_aHigh-Throughput Approaches to Biomarker Discovery and Challenges of Subsequent Validation -- Mass Spectrometry-Based Lipidomics for Biomarker Research -- Flow Cytometry as Platform for Biomarker Discovery and Clinical Validation -- Pentraxin 3 as Biomarker -- Isoprostanes as Biomarkers of Disease and Early Biological Effect -- Fetal Membranes: Potential Source of Preterm Birth Biomarkers -- 1-Hydroxypyrene as a Biomarker for Environmental Health -- Biomarkers of Necrosis and Myocardial Remodeling -- Serum Heat Shock Proteins as Novel Biomarker for Heart -- Failure and Cardiovascular Diseases -- Traditional and Proteomic Biomarkers of Autosomal Dominant -- Polycystic Kidney Disease (ADPKD) -- Biomarker for Amyotrophic Lateral Sclerosis -- Biomarkers of Vector Bites: Arthropod Immunogenic Salivary Proteins in Vector-Borne Diseases Control -- Biomarkers of Graft-Versus-Host Disease
520			_aOn an annual basis, over 17 million people die due to cardiovascular disease. This represents a third of all global deaths. The World Health Organisation have identified cardiovascular disease as the leading cause of death worldwide. Although many cardiovascular conditions are preventable, there is a need for accurate characterisation and diagnosis of cardiovascular conditions before, during and after treatments. Much of this characterisation entails the use of biological indicators, i.e biomarkers. Biomarkers in Cardiovascular Disease combines detailed information on different cardiovascular conditions and the concomitant application of conventional, new and emerging biomarkers. It covers the latest knowledge, trends and applications. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry
650	0	7	_aArterias _xEnfermedades _9681075 _2embne
650		7	_aCáncer _xInvestigación _0comprobar BNE19901364217 _2embne _9182523
700	1		_aPatel, Vinood B. _eeditor literario _985991 _0Local
700	1		_aPreedy, Victor R. _eeditor literario _985990 _0Local
710	2		_aSpringerLink (Online service) _0Local _9106996
830		0	_aBiomarkers in Disease: Methods, Discoveries and Applications _9133855
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-007-7678-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9789400776784
907			_a.b12959790 _b10-10-17 _c21-11-16
942			_2lcc _cLE
945			_aRC669.9 .B56 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11601048 _z06-04-17
988			_aEBOOK, EBSPRINGER
998			_am _a_alco _a_vill _b30-05-17 _cm _dz _eb _feng _gne _h0